Back to top
more

Better trading starts here.

Brokerage Reports

Research for GILD

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

3 items in cart

View Cart/Checkout

Gilead Sciences, Inc. [GILD]

Reports for Purchase

Showing records 101 - 120 ( 527 total )

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 101

02/15/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 102

02/11/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 103

02/01/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 104

01/25/2022

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 105

01/21/2022

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 35.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 106

12/28/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 107

12/20/2021

Daily Note

Pages: 3

Takeaways From our KOL Call on Vaccines and Therapies Targeting COVID-19

Provider: H.C. Wainwright & Co., Inc.

Analyst: RAMAKANTH S

Price: 5.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 108

11/29/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 109

11/15/2021

Industry Report

Pages: 6

Does Smoke from CD47 Program at SITC Signal Further Flames at ASH?

Provider: H.C. Wainwright & Co., Inc.

Analyst: FEIN A

Price: 12.50

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 110

11/01/2021

Industry Report

Pages: 17

Monthly Check-Up: November 2021

Provider: WEDBUSH SECURITIES INC.

Analyst: CHICO L

Price: 25.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 111

11/01/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 112

10/05/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 113

09/28/2021

Company Report

Pages: 10

ValuEngine Detailed Valuation Report for GILD

Provider: ValuEngine, Inc

Analyst: Research Department

Price: 25.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 114

09/06/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 115

08/10/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 116

07/09/2021

Company Report

Pages: 9

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 117

07/01/2021

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 118

06/21/2021

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 119

06/11/2021

Company Report

Pages: 24

Comprehensive Technical and Fundamental Analysis for GILD.

Provider: Stock Traders Daily

Analyst: Research Department

Price: 75.00

Research Provided by a Third Party

Company: Gilead Sciences, Inc.

Industry: Medical - Biomedical and Genetics

Record: 120

06/07/2021

Company Report

Pages: 8

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party